Benzisoselenazolethiones and process for the treatment of various diseases in humans

Claim 1

Benzisoselenazolethiones of the general formula I ##STR5## wherein R 1 and R 2 which can be identical or different, independently of one another are members selected from the group consisting of hydrogen, halogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, trifluoromethyl and nitro, and, R 1 and R 2 together, methylenedioxy, n is zero or an integer from 1 to 4, R 3 is a member selected from the group consisting of hydrogen, unsubstituted phenyl, the phenyl groups monosubstituted and those disubstituted by a member selected from the group consisting of halogen, alkyl, alkoxy, trifluoromethyl, nitro and methylenedioxy, and the heterocyclic groups selected from the group consisting of the unsubstituted thiophene, thiazole, isothiazole, imidazole, pyrazole, thiadiazole, pyridine, pyrimidine, pyrazine, pyridazine, benzothiazole, benzimidazole, benzotriazine, benzothiophene, benzothiadiazole, triazine, triazole, tetrazole, quinoline, isoquinoline, indole and indazole groups and such groups being monosubstituted by a member of the group consisting of halogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, mercapto, C 1 -C 4 -alkylmercapto, phenyl, nitro and trifluoromethyl, and such groups being identically or differently disubstituted by a member of the group consisting of halogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, mercapto, C 1 -C 4 -alkylmercapto, phenyl, nitro and trifluoromethyl.